Jia Shi

1.5k citations
39 papers · 575 indexed · h-index 14
Topics
Glioma Diagnosis and Treatment (5 papers)COVID-19 Clinical Research Studies (5 papers)Ferroptosis and cancer prognosis (4 papers)
Journals
SHILAP Revista de lepidopterologíaPLoS ONEOncogene
Partner nations
ChinaUnited States

In The Last Decade

Jia Shi

39 papers receiving 562 citations

Peers

Jia Shi
Comparison fields: 5 of 92
  • Molecular Biology 209
  • Infectious Diseases 145
  • Oncology 100
  • Cancer Research 93
  • Neurology 73
Replace Seung Hee Lee with:
Seung Hee Lee South Korea
Mitra Abbasifard Iran
Xiangrong Zuo China
Chuangyan Wu China
Binggang Xiang United States
Yanjia Chen China
Mei Xue China
Yaling Li China
Xiaofang Hu China
Xinyue Chen China
Jia Shi relative to Seung Hee Lee South Korea Seung Hee Lee's profile →
Citations per field
00.5×1.5×
Seung Hee Lee · 1×
Citations per year

Countries citing papers authored by Jia Shi

Since Specialization
Citations

This map shows the geographic impact of Jia Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jia Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jia Shi more than expected).

Fields of papers citing papers by Jia Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jia Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jia Shi. The network helps show where Jia Shi may publish in the future.

Co-authorship network of co-authors of Jia Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Jia Shi. A scholar is included among the top collaborators of Jia Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jia Shi. Jia Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 4
3 1
4 8
5 36
6 23
7 54
8 15
9 27
10 14
11 21
12 5
13 1
14 7
15 21
16 9
17 10
18 28
19 11
20
[Comparison of effects between China made sirolimus-eluting stents and bare stents for treating patients with acute myocardial infarction].
1

About Jia Shi

Jia Shi is a scholar working on Genetics, Cancer Research and Critical Care and Intensive Care Medicine, having authored 39 papers that have together received 575 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (5 papers), COVID-19 Clinical Research Studies (5 papers) and Ferroptosis and cancer prognosis (4 papers). The work is most often cited by research in Infectious Diseases (145 citations), Cancer Research (93 citations) and Genetics (53 citations). Jia Shi has collaborated with scholars based in China and United States. Frequent co-authors include Zongguo Yang, Xiaorong Chen, Yunfei Lu, Ying Lü, Bozong Tang, Chen Ye, Baopeng Tang, Qingnian Xu, Jun Dong and Wei Guan. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026